Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2005
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers
Maria Morganti, Monica Ciantelli, Beatrice Giglioni, et al.
International Journal of Cancer
|
April 12, 2019
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
Enrico Mini, Andrea Lapucci, Gabriele Perrone, et al.
Leukemia & Lymphoma
|
December 3, 2013
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma
Stefania Nobili, Cristina Napoli, Benedetta Puccini, et al.
Cancers
|
August 26, 2022
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
Valentina Russo, Eleonora Lallo, Armelle Munnia, et al.
Cancers
|
June 22, 2023
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma
Gabriele Perrone, Luigi Rigacci, Sara Urru, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2005
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers
Maria Morganti, Monica Ciantelli, Beatrice Giglioni, et al.
International Journal of Cancer
|
April 12, 2019
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
Enrico Mini, Andrea Lapucci, Gabriele Perrone, et al.
Leukemia & Lymphoma
|
December 3, 2013
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma
Stefania Nobili, Cristina Napoli, Benedetta Puccini, et al.
Cancers
|
August 26, 2022
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
Valentina Russo, Eleonora Lallo, Armelle Munnia, et al.
Cancers
|
June 22, 2023
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma
Gabriele Perrone, Luigi Rigacci, Sara Urru, et al.
Page
of 5